SEC Form 4 · accession 0001127602-17-009667
CVS HEALTH Corp · CVS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Larry J Merlo
Officer — President and CEO · Director
Period of report
Feb 28, 2017
Accepted (ET)
Mar 2, 2017 · 4:06 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000064803
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 28, 2017 | A | 68,255 | $80.58 | A | 310,467 | D | |
| Common StockF2 | Feb 28, 2017 | F | 32,722 | $80.58 | D | 277,745 | D | |
| Common Stock | holding | — | — | — | 360,627 | I | By Trust As Beneficiary | |
| Common Stock (restricted) | holding | — | — | — | 209,398 | D | ||
| ESOP Common Stock | holding | — | — | — | 6,643 | I | By ESOP | |
| Stock Unit | holding | — | — | — | 605,988 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Consists of stock awarded at market price pursuant to Issuer's 2010 Incentive Compensation Plan and its Long-Term Incentive Plan.
- F2Surrender of shares in payment of withholding taxes due upon the vesting of a stock award under the Registrant's 2010 Incentive Compensation Plan and its Long-Term Incentive Plan.